We are live on
!
Find out more
Vanguard Fiduciary Trust Portfolio holdings
AUM
$454B
This Fund
S&P 500
This Quarter
Est. Return
+25.89%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$454B
AUM Growth
+$58.2B
(+15%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
0.24%
Top 10 Holdings %
Top 10 Hldgs %
29.47%
Holding
4,173
New
110
Increased
2,642
Reduced
1,032
Closed
97
Avg Time Held
1
quarter
Top 10 Avg Time Held
0.9
quarters
Top 20 Avg Time Held
0.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$644M |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$393M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$173M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$170M |
| 5 |
SUNB
Sunbelt Rentals Holdings
SUNB
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$401M |
| 2 |
Apple
AAPL
|
+$206M |
| 3 |
Microsoft
MSFT
|
+$175M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.13% |
| 2 | Financials | 13.36% |
| 3 | Industrials | 10.07% |
| 4 | Healthcare | 9.55% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2326
Altimmune
ALT
$519M
| $3.93M | ﹤0.01% |
1,293,001
+423,683
| +49% | +$1.27M |
2026 Q1
1 quarter
|
|
2327
Sinclair Inc
SBGI
$914M
| $3.93M | ﹤0.01% |
275,762
+16,202
| +6% | +$233K |
2026 Q1
1 quarter
|
|
2328
Lexicon Pharmaceuticals
LXRX
$774M
| $3.92M | ﹤0.01% |
1,634,571
+302,287
| +23% | +$589K |
2026 Q1
1 quarter
|
|
2329
Cannae Holdings
CNNE
$676M
| $3.9M | ﹤0.01% |
270,729
-23,247
| -8% | -$316K |
2026 Q1
1 quarter
|
|
2330
Miller Industries
MLR
$616M
| $3.9M | ﹤0.01% |
76,173
+1,845
| +2% | +$88.7K |
2026 Q1
1 quarter
|
|
2331
LSB Industries
LXU
$733M
| $3.89M | ﹤0.01% |
359,584
+8,840
| +3% | +$118K |
2026 Q1
1 quarter
|
|
2332
Civista Bancshares
CIVB
$558M
| $3.88M | ﹤0.01% |
137,585
+1,685
| +1% | +$42.8K |
2026 Q1
1 quarter
|
|
2333
Ramaco Resources Class A
METC
$509M
| $3.88M | ﹤0.01% |
293,093
+7,124
| +2% | +$104K |
2026 Q1
1 quarter
|
|
2334
Achieve Life Sciences
ACHV
$723M
| $3.88M | ﹤0.01% |
593,751
+277,574
| +88% | +$1.32M |
2026 Q1
1 quarter
|
|
2335
U-Haul Holding Co
UHAL
$11.9B
| $3.87M | ﹤0.01% |
59,205
-549
| -0.9% | -$30.1K |
2026 Q1
1 quarter
|
|
2336
FTAI Infrastructure
FIP
$320M
| $3.87M | ﹤0.01% |
833,391
+33,588
| +4% | +$167K |
2026 Q1
1 quarter
|
|
2337
Insteel Industries
IIIN
$576M
| $3.86M | ﹤0.01% |
127,781
-3,486
| -3% | -$99.9K |
2026 Q1
1 quarter
|
|
2338
Daily Journal
DJCO
$898M
| $3.86M | ﹤0.01% |
6,413
-156
| -2% | -$81.1K |
2026 Q1
1 quarter
|
|
|
KMTS
2339
Kestra Medical Technologies
KMTS
$1.69B
| $3.85M | ﹤0.01% |
151,296
+5,599
| +4% | +$117K |
2026 Q1
1 quarter
|
|
|
TRAX
2340
First Tracks Biotherapeutics
TRAX
$1.18B
| $3.85M | ﹤0.01% |
+191,220
| New | +$3.57M |
2026 Q2
0 quarters
|
|
2341
Phathom Pharmaceuticals
PHAT
$542M
| $3.85M | ﹤0.01% |
354,573
+15,860
| +5% | +$181K |
2026 Q1
1 quarter
|
|
|
AVLN
2342
Avalyn Pharma
AVLN
$1.2B
| $3.84M | ﹤0.01% |
+116,763
| New | +$3.37M |
2026 Q2
0 quarters
|
|
2343
Hingham Institution for Saving
HIFS
$624M
| $3.84M | ﹤0.01% |
12,492
+121
| +1% | +$34.8K |
2026 Q1
1 quarter
|
|
2344
Forum Energy Technologies
FET
$1B
| $3.83M | ﹤0.01% |
76,214
+2,006
| +3% | +$112K |
2026 Q1
1 quarter
|
|
2345
Allogene Therapeutics
ALLO
$518M
| $3.82M | ﹤0.01% |
1,838,344
+746,535
| +68% | +$1.64M |
2026 Q1
1 quarter
|
|
2346
Columbia Financial
CLBK
$3.05B
| $3.81M | ﹤0.01% |
394,557
+6,215
| +2% | +$54.9K |
2026 Q1
1 quarter
|
|
2347
ClearPoint Neuro
CLPT
$351M
| $3.8M | ﹤0.01% |
213,246
+7,491
| +4% | +$93.6K |
2026 Q1
1 quarter
|
|
2348
CorMedix
CRMD
$566M
| $3.8M | ﹤0.01% |
484,322
-21,357
| -4% | -$169K |
2026 Q1
1 quarter
|
|
2349
Sprinklr
CXM
$1.21B
| $3.79M | ﹤0.01% |
734,754
-123,475
| -14% | -$656K |
2026 Q1
1 quarter
|
|
|
SLDE
2350
Slide Insurance Holdings
SLDE
$2.82B
| $3.79M | ﹤0.01% |
195,678
-19,974
| -9% | -$362K |
2026 Q1
1 quarter
|
|
Similar funds
Vanguard Fiduciary Trust's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Fiduciary Trust held 4,173 positions worth $454B, up 15% from $396B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 5%. Vanguard Fiduciary Trust opened 110 new positions and exited 97, leaving the 4,173-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.
- Vanguard Fiduciary Trust's largest Q2 2026 buy was SpaceX: 3,791,999 shares worth $648M.
- Vanguard Fiduciary Trust added most to Alphabet (Google) Class A in Q2 2026, an estimated $173M increase.
- Vanguard Fiduciary Trust's biggest Q2 2026 reduction was Honeywell, cutting an estimated $401M.
- Vanguard Fiduciary Trust fully exited Coterra Energy in Q2 2026, selling an estimated $149M.
- Vanguard Fiduciary Trust's ten largest holdings make up 29% of its $454B portfolio in Q2 2026.
- Vanguard Fiduciary Trust opened 110 new positions and closed 97 in Q2 2026.
- Vanguard Fiduciary Trust's portfolio value rose 15% quarter-over-quarter to $454B.
Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.